Genflow Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:GENF.F Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
27 Mar 25	BuyUS$31,298	Eric Leire	Individual		2,100,000	US$0.015

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of GENF.F?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	6,600,000	1.34%
General Public	80,586,636	16.3%
Institutions	173,429,192	35.1%
Individual Insiders	232,932,114	47.2%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 41.1%.

Top Shareholders

Top 25 shareholders own 81.23% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
26.6%	Eric Leire	131,060,453	US$3.5m	5.34%	no data
12.1%	Jonathan Swann	59,861,278	US$1.6m	63.6%	no data
11%	Aberdeen Group Plc	54,066,067	US$1.4m	42.3%	no data
8.5%	Hargreaves Lansdown Asset Management Ltd.	41,942,244	US$1.1m	-2.88%	no data
4.09%	Moayyed Alqurtas	20,182,883	US$537.2k	0%	no data
3.54%	Adrian Beeston	17,475,000	US$465.1k	0%	no data
1.93%	KBC Asset Management NV	9,514,944	US$253.2k	145%	no data
1.62%	Longevity Tech Fund A.S.	7,999,998	US$212.9k	0%	no data
1.56%	HBOS Investment Fund Managers Limited	7,698,133	US$204.9k	-39.8%	no data
1.44%	Barclays Bank PLC	7,102,525	US$189.0k	26%	no data
1.3%	HSBC Global Asset Management (UK) Limited	6,434,022	US$171.2k	7.01%	no data
0.99%	IG Group Holdings plc	4,862,606	US$129.4k	-28.6%	0.01%
0.97%	Bevilacqua PLLC	4,800,000	US$127.7k	0%	no data
0.94%	UBS Asset Management AG	4,623,691	US$123.1k	327%	no data
0.81%	GHC Capital Markets Ltd.	4,015,908	US$106.9k	-53.9%	0.13%
0.59%	CM-CIC Asset Management SA	2,902,076	US$77.2k	0%	no data
0.51%	Eurizon Capital SGR SpA	2,496,925	US$66.5k	0%	no data
0.49%	Raymond James Wealth Management Limited	2,412,005	US$64.2k	-38.8%	no data
0.45%	Cantor Fitzgerald Asset Management	2,200,000	US$58.6k	0%	no data
0.35%	TD Asset Management, Inc.	1,719,500	US$45.8k	0%	no data
0.34%	James Brearley & Sons Ltd.	1,679,683	US$44.7k	0%	0.01%
0.32%	Raiffeisenlandesbank Oberösterreich Aktiengesellschaft	1,554,981	US$41.4k	0%	no data
0.31%	Peel Hunt LLP	1,511,021	US$40.2k	1,140%	0.01%
0.3%	Newmarket Strategy Ltd	1,500,000	US$39.9k	0%	no data
0.26%	Yassine Bendiabdallah	1,270,500	US$33.8k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/02/01 14:43
End of Day Share Price	2026/01/21 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Genflow Biosciences plc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.